Avalo Therapeutics
AVTX
AVTX
71 hedge funds and large institutions have $176M invested in Avalo Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0.02% → 0.03% (+0%)
8% less call options, than puts
Call options by funds: $210K | Put options by funds: $229K
21% less capital invested
Capital invested by funds: $223M → $176M (-$47.7M)
Holders
71
Holding in Top 10
1
Calls
$210K
Puts
$229K
Top Buyers
| 1 | +$12.9M | |
| 2 | +$10.3M | |
| 3 | +$2.07M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.85M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.37M |
Top Sellers
| 1 | -$5.18M | |
| 2 | -$917K | |
| 3 | -$881K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$388K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$320K |